SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 19, 17:00
604.55
-1.2 (-0.2%)
VOLUME 122,508
LIVE
NSE
Sep 19, 17:00
602.50
-4.05 (-0.67%)
VOLUME 1,788,206
News on Ranbaxy Laboratories
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Hold Sun Pharma; may test Rs 855-860: Akshata Deshmukh 

3.02 pm | 19 Sep 2014 |  Source: CNBC-TV18

Akshata Deshmukh of Networth Stock Broking is of the view that one may hold Sun Pharmaceutical Industries....

Stocks in news: Tata Motors, GTL Infra, ICICI, Cipla, SPML

8.22 am | 19 Sep 2014 |  Source: CNBC-TV18

Tata Motors | Tata Chemicals | Tata Steel | Tata Power | Tech Mahindra | Bosch | GTL Infrastructure | SBI | Axis Bank | ICICI Bank | Manappuram Financ...

NPPA reviews drugs under price control list; rejigs some 

5.55 pm | 18 Sep 2014 |  Source: CNBC-TV18

The national pharmaceutical pricing authority (NPPA) has widened its ambit by adding new strengths of 43 drugs under price control, out of which major...

Buy Crompton, Ranbaxy; sell Rel Cap: Meghana Malkan 

1.37 pm | 18 Sep 2014 |  Source: CNBC-TV18

Meghana Malkan of malkansview.com is of the view that one may buy Ranbaxy Laboratories for a target price of Rs 615 and sell Reliance Capital for a ta...

Here are top 10 stocks to watch on Sep 18 

8.46 am | 18 Sep 2014 |  Source: CNBC-TV18

Here are top 10 stocks to watch on Sep 18 - GMR Infra, Reliance Industries, Sun Pharma, Ranbaxy, Texrail, ITC, MCX, Yes Bank, Rel Comm and Aegis Logis...

Bull's Eye: Buy Siemens, Crompton, NBCC, Ranbaxy, Biocon 

8.46 am | 18 Sep 2014 |  Source: CNBC-TV18

Meghana V Malkan, malkansview.com advises buying Crompton Greaves for a target price of Rs 221 and Century Textiles for a target price of Rs 595....

Stocks in news: Sun Pharma, Ranbaxy, YES Bank, Apollo Tyres

8.24 am | 18 Sep 2014 |  Source: CNBC-TV18

Sun Pharma | Ranbaxy Labs | NCC | SPML Infra | Chambal Fertilizers | YES Bank | GTL Infrastructure | Apollo Tyres | Samruddhi Realty | Mirc Electronic...

Super Six buy or sell calls for September 18

8.24 am | 18 Sep 2014 |  Source: CNBC-TV18

Vishal Malkan of malkansview.com advises buying Ranbaxy Laboratories with a target of Rs 620-630 and Crompton Greaves with a target of Rs 222-226....

Ranbaxy receives CID from US Justice Department 

7.30 pm | 17 Sep 2014 |  Source: CNBC-TV18

A civil investigative demand in this case means that the US department of justice is reviewing the documents and information regarding how Ranbaxy pri...

Buy Ranbaxy; sell Rel Cap, CESC, Adani Ent: Meghana Malkan 

1.58 pm | 17 Sep 2014 |  Source: CNBC-TV18

Meghana V Malkan of malkansview.com recommends selling Adani Enterprises with a target of Rs 475 and CESC with a target of Rs 748....

Bull's Eye: Buy Lupin, HDFC; short HDIL, Reliance Capital 

8.56 am | 17 Sep 2014 |  Source: CNBC-TV18

Meghana V Malkan, malkansview.com advises buying Ranbaxy Labs for a target price of Rs 615 and selling Reliance Capital for a target price of Rs 495....

Epirus, Ranbaxy win India approval for arthritis drug copy

8.08 am | 16 Sep 2014 |  Source: Reuters

The market for copycat biotech drugs, known as biosimilars, is becoming more lucrative as patents expire on older, high-priced antibody drugs that ran...

Pfizer, Ranbaxy win dismissal of lawsuit over Lipitor

12.41 pm | 13 Sep 2014 |  Source: Reuters

The lawsuit stems from a 2008 settlement of a patent lawsuit filed by Pfizer against Ranbaxy over Ranbaxy's plan to make generic Lipitor. Under the de...

Halol contributes 35-40% to Sun's US sales: Angel Broking  

10.54 am | 11 Sep 2014 |  Source: CNBC-TV18

Nangra believes that most pharma stocks are trading at fair valuations post the recent run-up in the market. She likes Dr Reddys and IPCA Labs in the ...

Sun Pharma down 6% on surprise audit by USFDA at Halol unit

9.56 am | 11 Sep 2014 |  Source: Moneycontrol.com

Sources say Sun Pharma was taken by surprise when a team of 5 inspectos of United States Food and Drug Administration (US FDA) walked in on Monday mor...

US drug patent expiries to benefit Indian pharma industry

9.00 am | 11 Sep 2014 |  Source: PTI

Indian pharmaceutical companies have an opportunity to capitalise on the patent cliff and gain a greater share of the growing generics market....

Jyotivardhan Jaipuria neutral on pharma space 

1.29 pm | 10 Sep 2014 |  Source: CNBC-TV18

Jyotivardhan Jaipuria, Head of Research, BofA ML is neutral on pharma space....

Sun Pharma shares gain; Credit Suisse raises target

1.51 pm | 08 Sep 2014 |  Source: Moneycontrol.com

According to the brokerage, approval of Ranbaxy merger (expected before FY15 end) and use of cash are key catalysts. Sun has cash of USD 2 billion (yi...

CCI begins Sun-Ranbaxy deal's public scrutiny; seeks notes

1.02 pm | 04 Sep 2014 |  Source: PTI

The CCI said the public consultation process has been launched "in order to determine whether the combination has or is likely to have an appreciable ...

Buy Ranbaxy Laboratories, says Manas Jaiswal 

2.35 pm | 02 Sep 2014 |  Source: CNBC-TV18

Manas Jaiswal of manasjaiswal.com recommends buying Ranbaxy Laboratories as the stock may touch Rs 680 in next two to three trading sessions....

1 2 3 4 5 6
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.